Briggs M, Nelson E A
Centre for the Analysis of Nursing Practice (CANP), Leeds Community and Mental Health Trust, Meanwood Park Hospital, Leeds, West Yorkshire, UK, LS6 4QB.
Cochrane Database Syst Rev. 2000(2):CD001177. doi: 10.1002/14651858.CD001177.
Venous leg ulcers affect up to 1 per cent of people at some time in their life. These ulcers are often painful and some clinicians choose dressings to reduce the pain both during and between dressing changes.
To assess the effectiveness of dressings, local anaesthetics/analgesics for pain relief in venous leg ulceration.
Cochrane Wounds Group Register and the Cochrane Collaboration Field in Complementary Medicine were searched. Cochrane Pain Palliative and Supportive Care Group and Cochrane Wounds Group strategy were combined and used.
All randomised controlled trials which evaluated local interventions used to relieve venous leg ulcer pain were considered. Pain was defined as either persistent pain or pain at dressing changes or debridement.
Eligibility for inclusion was confirmed by two reviewers who independently assessed the all potential trials. Details of eligible studies were summarised using a data extraction sheet which was checked by the second reviewer.
No trial evaluated interventions for persistent pain. Three trials compared a eutectic mixture of local anaesthetic (EMLA) versus placebo for pain at debridement. All 3 trials reported a significant difference in pain in favour of EMLA, however, one of the trials favoured placebo in terms of number of ulcers healed at the end of the trial and another trial noted an increased incidence of burning and itching with the use of EMLA.
REVIEWER'S CONCLUSIONS: EMLA may provide pain relief for venous leg ulcer debridement however, the effect of the product on ulcer healing and the incidence of itching and burning is unclear. Research is required to address questions such as the benefits of leg ulcer debridement and the impact of EMLA on healing and the incidence of burning and itching. There were no trials addressing the treatment of persistent pain and further research is warranted.
腿部静脉溃疡在一生中的某些时候会影响多达1%的人群。这些溃疡常常疼痛,一些临床医生会选择敷料以在换药期间及换药间隔时减轻疼痛。
评估敷料、局部麻醉剂/镇痛药对缓解腿部静脉溃疡疼痛的有效性。
检索了Cochrane伤口组登记册以及补充医学领域的Cochrane协作网。将Cochrane疼痛、姑息与支持治疗组和Cochrane伤口组的检索策略合并使用。
纳入所有评估用于缓解腿部静脉溃疡疼痛的局部干预措施的随机对照试验。疼痛定义为持续性疼痛或换药或清创时的疼痛。
两名审阅者独立评估所有潜在试验,确认纳入资格。使用数据提取表总结符合条件研究的详细信息,该表由第二名审阅者检查。
没有试验评估针对持续性疼痛的干预措施。三项试验比较了局部麻醉剂的共熔混合物(EMLA)与安慰剂在清创时疼痛方面的效果。所有三项试验均报告在疼痛方面EMLA有显著差异,但有一项试验在试验结束时愈合溃疡数量方面更倾向于安慰剂,另一项试验指出使用EMLA时烧灼和瘙痒的发生率增加。
EMLA可能为腿部静脉溃疡清创提供疼痛缓解,然而该产品对溃疡愈合以及瘙痒和烧灼发生率的影响尚不清楚。需要开展研究以解决诸如腿部溃疡清创益处以及EMLA对愈合及烧灼和瘙痒发生率影响等问题。没有试验涉及持续性疼痛的治疗,有必要进行进一步研究。